Fibers in therapy and cosmetics

• US 9,539,438 B2
• Filed: 02/15/2011
• Issued: 01/10/2017
• Est. Priority Date: 03/11/2010
• Status: Expired due to Fees

• Current Assignee: Merck Patent GmbH (Merck & Co., Inc.)
• Original Assignee: Merck Patent GmbH (Merck & Co., Inc.)
• Inventors: Pan, Junyou, Buchholz, Herwig, Aydt, Ewald
• Primary Examiner(s): Thomson, William
• Assistant Examiner(s): Shapiro, Victor
• Application Number:
  US13/634,101
• Publication Number:
  US 20130006119A1
• Time in Patent Office: 2,156 Days
• Field of Search: 422/24, 602/41, 602/58, 604/20, 607/88, 313/502
• US Class Current: 1/1
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/441 Skin evaluation, e.g. for skin disorder diagnosis
• CPC Class Codes: A61N 2005/063 comprising light transmitting means, e.g. optical fibres
• CPC Class Codes: A61N 2005/0645 Applicators worn by the patient
• CPC Class Codes: A61N 2005/0653 Organic light emitting diodes
• CPC Class Codes: A61N 2005/0663 Coloured light
• CPC Class Codes: A61N 5/0616 Skin treatment other than tanning
• CPC Class Codes: A61N 5/0618 Psychological treatment
• CPC Class Codes: A61N 5/062 Photodynamic therapy, i.e. excitation of an agent
• CPC Class Codes: A61N 5/0621 Hyperbilirubinemia, jaundice treatment
• CPC Class Codes: A61N 5/0624 for eliminating microbes, germs, bacteria on or in the body
• CPC Class Codes: H10K 2101/30 Highest occupied molecular orbital [HOMO], lowest unoccupied molecular orbital [LUMO] or Fermi energy values
• CPC Class Codes: H10K 2101/40 Interrelation of parameters between multiple constituent active layers or sublayers, e.g. HOMO values in adjacent layers
• CPC Class Codes: H10K 50/11 characterised by the electroluminescent [EL] layers
• CPC Class Codes: H10K 50/15 Hole transporting layers
• CPC Class Codes: H10K 50/16 Electron transporting layers
• CPC Class Codes: H10K 50/17 Carrier injection layers
• CPC Class Codes: H10K 50/171 Electron injection layers
• CPC Class Codes: H10K 50/18 Carrier blocking layers
• CPC Class Codes: H10K 50/182 OLED comprising a fiber structure
• CPC Class Codes: H10K 85/113 : Heteroaromatic compounds comprising sulfur or selene, e.g. polythiophene
• CPC Class Codes: H10K 85/115 : Polyfluorene; Derivatives thereof
• CPC Class Codes: H10K 85/151 : Copolymers
• CPC Class Codes: Y02E 10/549 : Organic PV cells
• CPC Class Codes: Y10T 29/49826 : Assembling or joining

Abstract

The present invention relates inter alia to functional materials for the treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions. The functional materials can be used for the preparation of light emitting devices comprising fibers as light emitting elements.

Claims

1. A method of preparing a device for the treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions which comprises utilizing a functional material selected from host materials, emissive materials (EM), hole injection materials (HIM), hole transport materials (HTM), hole blocking materials (HBM), electron injection materials (EIM), electron transport materials (ETM), electron blocking materials (EBM), exciton blocking materials (ExBM), and metal complexes, wherein the device comprises at least one organic light emitting woven fiber and the device is an implantable probe, nasogastric tube, chest drain or stent.

2. The method as claimed in claim 1, wherein the fiber comprises a fiber core having an outer first electrode;

at least one organic light emitting layer positioned over an outer surface of the first electrode; and

a light transmissive second electrode positioned over the organic light emitting layer;

wherein the at least one organic light emitting layer comprises at least one organic material that emits light when a voltage is applied across the first and second electrode.

3. The method as claimed in claim 1, wherein the device is an ambulatory device and comprises an attachment means for attaching the device to a human or animal subject.

4. The method as claimed in claim 1, wherein the organic light emitting fiber is an organic light emitting diode (OLED).

5. The method as claimed in claim 1, wherein the device is used in a method for the treatment and/or prophylaxis and/or diagnosis of skin diseases and/or cosmetic skin conditions.

6. The method as claimed in claim 1, wherein the device is used in a method for the treatment and/or prophylaxis and/or diagnosis of skin diseases and/or cosmetic skin conditions selected from acne, psoriasis, eczema, dermatitis, atopic dermatitis, edema, vitiligo, Bowens disease, tumors, pre-malignant tumors, malignant tumors, basal cell carcinomas, squamous cell carcinomas, secondary metastases, cutaneous T-cell lymphomas, solar keratosis, arsenical keratosis, radiodermatitis, and cellulite.

7. The method as claimed in claim 1, wherein the device is used in a method for the treatment and/or prophylaxis and/or diagnosis of infections and inflammatory, neurological, and psychological diseases and/or conditions.

8. The method as claimed in claim 1, wherein the device is used in a method for the disinfection of soft drinks, beverages, water, drinking water, foodstuff, and nutrition.

9. The method as claimed in claim 1, wherein the device is used in a method for the application in photodynamic therapy (PDT).

10. The method as claimed in claim 1, wherein the device is used in a method for the treatment and/or prophylaxis of jaundice and crigler naijar.

13. The method as claimed in claim 1, wherein the device is an implantable probe.

14. The method as claimed in claim 1, wherein the device is a nasogastric tube.

15. The method as claimed in claim 1, wherein the device is a chest drain or stent.

11. A method for the treatment and/or prophylaxis and/or diagnosis of diseases and/or conditions which comprises utilizing an organic light emitting woven fiber.

12. The method as claimed in claim 11, wherein the conditions are diagnosis of cosmetic conditions.